MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, FBIOP made $63,262K in revenue. -$1,882K in net income. Net profit margin of -2.97%.

Income Overview

Revenue
$63,262K
Net Income
-$1,882K
Net Profit Margin
-2.97%
EPS
-$0.07
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product revenue, net
    • Avenue Therapeutics Inc
    • Journey
Revenue Breakdown
    • Journey
    • Avenue Therapeutics Inc
Revenue Breakdown
    • Revenue from contract with custo...
    • Revenue from contract with custo...
    • Revenue from contract with custo...
    • Others

Income Statement
2025-12-31
Net revenue
63,262
Cost of goods - (excluding amortization of acquired intangible assets)
20,924
Amortization of acquired intangible assets
4,258
Research and development
11,901
Selling, general and administrative
96,400
Total operating expenses
133,483
Loss from operations
-70,221
Interest income
2,485
Interest expense and financing fee
10,106
Loss on common stock warrant liabilities
-398
Gain from deconsolidation of subsidiary
27,127
Other income
17,578
Total other income (expense)
36,686
Loss before income tax expense
-33,535
Income tax expense (benefit)
-620
Net loss
-32,915
Attributable to non-controlling interests
-39,730
Net income (loss) attributable to fortress
6,815
Preferred a dividends declared and paid and/or cumulated, and fortress' share of subsidiary deemed dividends
8,697
Net loss attributable to common stockholders
-1,882
Basic EPS
-0.07
Diluted EPS
-0.07
Basic Average Shares
27,901,889
Diluted Average Shares
27,901,889
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Attributable tonon-controlling interests-$39,730K Net lossattributable to common...-$1,882K Net income (loss)attributable to fortress$6,815K Net loss-$32,915K Income tax expense(benefit)-$620K Gain fromdeconsolidation of subsidiary$27,127K Other income$17,578K Avenue TherapeuticsInc$1,404K Journey$619K Interest income$2,485K Preferred a dividendsdeclared and paid and/or...$8,697K Loss before incometax expense-$33,535K Total other income(expense)$36,686K Product revenue, net$61,239K Other revenue$2,023K Interest expense andfinancing fee$10,106K Loss on common stockwarrant liabilities-$398K Loss from operations-$70,221K Net revenue$63,262K Total operatingexpenses$133,483K Selling, general andadministrative$96,400K Cost of goods -(excluding amortization of...$20,924K Research and development$11,901K Amortization of acquiredintangible assets$4,258K

Fortress Biotech, Inc. (FBIOP)

Fortress Biotech, Inc. (FBIOP)